Urometer Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 – 2032
The Global Urometer Market was valued at USD 512.4 million in 2023 and is projected to grow at a CAGR of 7.2% from 2024 to 2032. This growth is largely driven by advancements in urometer technology, the rising prevalence of kidney disorders and urinary diseases, the aging global population, and an increasing number of surgeries and ICU admissions. The market is segmented by product type into capacities such as 100 ml, 200 ml, 400 ml, 450 ml, 500 ml, and above 500 ml. In 2023, the 500 ml segment led the market, generating USD 177 million in revenue. These urometers are widely used in critical care environments like intensive care units (ICUs) and post-operative wards, where precise urine output monitoring is essential.
The 500 ml capacity is optimal for adult patients, enabling accurate measurements over short intervals without the need for frequent emptying. This is crucial in monitoring conditions such as acute kidney injury (AKI) and sepsis. By usability, the market is categorized into disposable and reusable urometers. In 2023, disposable urometers dominated with an 82.3% market share.
Their popularity stems from the convenience they offer healthcare providers by eliminating the need for cleaning and sterilization. This makes disposable urometers particularly valuable in high-turnover environments like ICUs, emergency rooms, and operating theaters. While the initial cost may be higher than reusable devices, the savings in labor and reprocessing costs make disposable options more cost-effective for many healthcare facilities. North America held a significant share of the urometer market in 2023, accounting for USD 202.4 million in revenue.The region's well-established healthcare infrastructure and advanced medical facilities contribute to the increased adoption of urometers, particularly in critical care and surgical settings. As hospitals and clinics prioritize accurate urine output monitoring, the demand for these devices is expected to grow steadily.
The 500 ml capacity is optimal for adult patients, enabling accurate measurements over short intervals without the need for frequent emptying. This is crucial in monitoring conditions such as acute kidney injury (AKI) and sepsis. By usability, the market is categorized into disposable and reusable urometers. In 2023, disposable urometers dominated with an 82.3% market share.
Their popularity stems from the convenience they offer healthcare providers by eliminating the need for cleaning and sterilization. This makes disposable urometers particularly valuable in high-turnover environments like ICUs, emergency rooms, and operating theaters. While the initial cost may be higher than reusable devices, the savings in labor and reprocessing costs make disposable options more cost-effective for many healthcare facilities. North America held a significant share of the urometer market in 2023, accounting for USD 202.4 million in revenue.The region's well-established healthcare infrastructure and advanced medical facilities contribute to the increased adoption of urometers, particularly in critical care and surgical settings. As hospitals and clinics prioritize accurate urine output monitoring, the demand for these devices is expected to grow steadily.
Report Content
CHAPTER 1 METHODOLOGY & SCOPE
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of chronic diseases
3.2.1.2 Increase in surgeries and critical care
3.2.1.3 Technological advancements
3.2.2 Industry pitfalls & challenges
3.2.2.1 Risk of catheter-associated urinary tract infections
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Gap analysis
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Value chain analysis
3.10 Future market trends
CHAPTER 4 COMPETITIVE LANDSCAPE, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY PRODUCT, 2021 – 2032 ($ MN)
5.1 Key trends
5.2 100 ml
5.3 200 ml
5.4 400 ml
5.5 450 ml
5.6 500 ml
5.7 Above 500 ml
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY USABILITY, 2021 – 2032 ($ MN)
6.1 Key trends
6.2 Disposable
6.3 Reusable
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021 – 2032 ($ MN)
7.1 Key trends
7.2 Operative procedures
7.3 Emergency trauma
7.4 Palliative care
7.5 Other applications
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY END USE, 2021 – 2032 ($ MN)
8.1 Key trends
8.2 Hospital
8.3 Clinics
8.4 Home care settings
8.5 Other end-users
CHAPTER 9 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 – 2032 ($ MN)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
CHAPTER 10 COMPANY PROFILES
10.1 Advin Health Care
10.2 Angiplast Private Limited
10.3 B. Braun Melsungen AG
10.4 Becton, Dickinson and Company
10.5 Cardinal Health, Inc.
10.6 Convatec Inc.
10.7 Fannin
10.8 Forlong Medical Co.,Ltd.
10.9 Hitec Medical Co., Ltd.
10.10 Laborie
10.11 Medline Industries, LP
10.12 Observe Medical ASA
10.13 Romsons Group
10.14 Sterimed Group
10.15 Teleflex Incorporated
CHAPTER 1 METHODOLOGY & SCOPE
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of chronic diseases
3.2.1.2 Increase in surgeries and critical care
3.2.1.3 Technological advancements
3.2.2 Industry pitfalls & challenges
3.2.2.1 Risk of catheter-associated urinary tract infections
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Gap analysis
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Value chain analysis
3.10 Future market trends
CHAPTER 4 COMPETITIVE LANDSCAPE, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY PRODUCT, 2021 – 2032 ($ MN)
5.1 Key trends
5.2 100 ml
5.3 200 ml
5.4 400 ml
5.5 450 ml
5.6 500 ml
5.7 Above 500 ml
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY USABILITY, 2021 – 2032 ($ MN)
6.1 Key trends
6.2 Disposable
6.3 Reusable
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021 – 2032 ($ MN)
7.1 Key trends
7.2 Operative procedures
7.3 Emergency trauma
7.4 Palliative care
7.5 Other applications
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY END USE, 2021 – 2032 ($ MN)
8.1 Key trends
8.2 Hospital
8.3 Clinics
8.4 Home care settings
8.5 Other end-users
CHAPTER 9 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 – 2032 ($ MN)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
CHAPTER 10 COMPANY PROFILES
10.1 Advin Health Care
10.2 Angiplast Private Limited
10.3 B. Braun Melsungen AG
10.4 Becton, Dickinson and Company
10.5 Cardinal Health, Inc.
10.6 Convatec Inc.
10.7 Fannin
10.8 Forlong Medical Co.,Ltd.
10.9 Hitec Medical Co., Ltd.
10.10 Laborie
10.11 Medline Industries, LP
10.12 Observe Medical ASA
10.13 Romsons Group
10.14 Sterimed Group
10.15 Teleflex Incorporated
